We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Bronchial Response to Mannitol and Inflammation in Steroid Naive Asthmatics.

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2005 by Bispebjerg Hospital.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00206973
First Posted: September 21, 2005
Last Update Posted: September 21, 2005
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Bispebjerg Hospital
  Purpose
Study on the relationship between the response of the airways to a bronchial provocation test with mannitol and the degree of airway inflammation in asthma patients.

Condition Intervention
Asthma Procedure: mannitol test

Study Type: Observational
Study Design: Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: Bronchial Response to Mannitol and Inflammation in Steroid Naive Asthmatics

Resource links provided by NLM:


Further study details as provided by Bispebjerg Hospital:

Estimated Enrollment: 40
Study Start Date: August 2005
Estimated Study Completion Date: September 2005
Detailed Description:
Study on the relationship between the response of the airways to a bronchial provocation test with mannitol and the degree of airway inflammation in asthma patients.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Steroid naive asthma.
  • Non-smoker

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00206973


Contacts
Contact: Celeste Porsbjerg, MD +45 35313069 porsbjerg@dadlnet.dk

Locations
Denmark
Respiratory Research Unit, Med. Clinic I, Bispebjerg Hospital, Bispebjerg Bakke 23 Recruiting
Copenhagen, NV, Denmark, 2400
Contact: Celeste Porsbjerg, MD    + 45 35313069    porsbjerg@dadlnet.dk   
Contact: Vibeke Backer, MD    35313069    backer@dadlnet.dk   
Principal Investigator: Celeste Porsbjerg, MD         
Sponsors and Collaborators
Bispebjerg Hospital
Investigators
Principal Investigator: Celeste porsbjerg, MD unaffilliated
  More Information

ClinicalTrials.gov Identifier: NCT00206973     History of Changes
Other Study ID Numbers: 7654 - man 05
First Submitted: September 13, 2005
First Posted: September 21, 2005
Last Update Posted: September 21, 2005
Last Verified: September 2005

Additional relevant MeSH terms:
Inflammation
Pathologic Processes
Mannitol
Diuretics, Osmotic
Diuretics
Natriuretic Agents
Physiological Effects of Drugs